Despite tremendous effort, the molecular and cellular basis of cognitive deficits in schizophrenia remain poorly understood. Recent progress in elucidating the genetic architecture of schizophrenia has highlighted the association of multiple loci and rare variants that may impact susceptibility. One key example, given their potential etiopathogenic and therapeutic relevance, is a set of genes that encode proteins that regulate excitatory glutamatergic synapses in brain.
Introduction
Neuropsychiatric disorders are devastating illnesses affecting brain function that cause tremendous suffering in patients and families worldwide. Intellectual disability neurodevelopmental (ID/NDD) disorders, with an overall prevalence of ~1%, comprise a heterogeneous group of largely monogenic disorders that feature severe cognitive deficits either alone or in combination with syndromes of effects across other body systems (Vissers et al., 2016) . Schizophrenia (SCZ), with a lifetime prevalence of ~0.7% (McGrath et al., 2008) , features positive symptoms (hallucinations, delusions), negative symptoms (flat affect, avolition), and cognitive deficits (Kahn & Keefe, 2013; Tandon et al., 2013) . While ID/NDD and SCZ are clearly distinct disorders (e.g. ID/NDD is typically found in young children, while SCZ typically first presents in late adolescence/early adulthood), the shared domain of cognitive deficits suggests some convergent dysfunction.
Recent large-scale exome sequencing and genome-wide association efforts have yielded tremendous progress in identifying the genetic risk factors for neuropsychiatric diseases.
For ID/NDD, over 700 risk genes have been identified (Vissers et al., 2016 ). Common and rare variants contributing to schizophrenia (SCZ) risk have been identified at over 100 genomic loci (Ripke et al., 2014; Fromer et al., 2014; Purcell et al., 2014; Genovese et al., 2016; Pardiñas et al., 2018) . In comparisons of the cell biological functions of ID/NDD and SCZ risk genes, a number of common themes emerge (Cristino et al., 2014; Hormozdiari et al., 2015) , which may reflect the commonality of cognitive deficits across these disorders. In particular, numerous ID/NDD and SCZ risk genes play key roles within pre-synaptic and post-synaptic specializations in neurons in the central nervous system. On the pre-synaptic side, studies suggest dysregulation of presynaptic vesicle recruitment, docking, release, and recycling in both ID/NDD (e.g. Broek et al., 2016; Pechstein et al., 2010) and schizophrenia (Eqbujo et al., 2016) . Postsynaptically, many ID/NDD and SCZ risk genes regulate glutamate receptor signaling (Volk et al., 2015) , as well as the dendritic spine actin cytoskeleton via effects on RHO GTPase and CAMKII signaling (Hall et al., 2015; Vissers et al., 2016) . Thus, the synapse is a hot spot for neuropsychiatric disease risk gene pathology.
Here we investigated GIT1, a synaptic signaling and scaffolding protein (reviewed in Zhou et al., 2016) . We propose that GIT1 plays central roles in synaptic neuropsychiatric disease risk gene pathology. Rare coding variants in GIT1 are found in schizophrenia patients Purcell et al., 2014) . Several of these schizophrenia-associated coding variants disrupt GIT1 activation of the p21-activated kinase PAK3 (Kim et al., 2016) , a kinase with expression levels that are dysregulated in the brains of schizophrenia patients (Datta et al., 2015) . Recently, a splice acceptor site variant in GIT1 was found in a schizophrenia patient (Genovese et al., 2016) . In addition, copy number variation at the GIT1 locus, including both deletions and duplications, has been reported in patients with ID/NDD (Uddin et al., 2016) . The fact that GIT1 is a loss of function intolerant gene (Lek et al., 2016) strengthens the notion that these variants are pathological. Lastly, GIT1 has been reported to physically interact or form complexes with the schizophrenia risk gene products CNKSR2 (Lim et al., 2014; Ripke et al., 2014 ; CNSKR2 is also an ID risk gene- Houge et al., 2012) , PTPRF Ripke et al., 2014) , and GRIA1 Ripke et al., 2014) , as well as the ID/NDD risk gene products ARHGEF6 (Kutsche et al., 2000; Bagrodia et al., 1999) and PAK3 (Allen et al., 1998; Bagrodia et al., 1999) , all of which can be found at the synapse or at post-synaptic dendritic spines (Zhang et al., 2003; Collins et al., 2006; Zhang et al., 2005) . These data strongly support the notion that GIT1 is a key protein that may regulate the function of multiple neuropsychiatric disease risk genes that may be involved in cognitive function.
GIT1 has been reported to function on both the pre-synaptic and post-synaptic sides of synapses (reviewed in Zhou et al., 2016) . In pre-synaptic terminals, GIT1 binds to the active zone cytomatrix protein PCLO . Functionally, presynaptic GIT1 regulates the probability of vesicle release (Montesinos et al., 2015) . On the post-synaptic side, GIT1
facilitates targeting of AMPA receptors to the post-synaptic density and the synaptic membrane . In addition, GIT1 plays key roles in dendritic spine formation and morphology (Zhang et al., 2003) by interacting with a number of proteins that regulate the actin cytoskeleton in spines, such as RAC1 and PAK3 (Zhang et al., 2005) . With these multiple pre-and postsynaptic roles, GIT1 is a central regulator of synaptic transmission.
Given the key roles of GIT1 on both sides of synapses, involving interactions with ID/NDD and SCZ risk gene products, it is perhaps not surprising that GIT1 loss of function in knockout mice causes cognitive deficits, such as decreased fear conditioning learning (Schmalzigaug et al., 2009) , an absence of novel object recognition and reduced spatial learning and memory in the Morris water maze test (Won et al., 2011; Martyn et al., 2018) , and impaired performance during operant learning (Menon et al., 2010) . However, all previous studies in GIT1 loss of function mice involved whole body knockout; these mice suffer from substantial post-natal lethality (Schmalziqaug et al., 2009 ) as well as impaired lung development (Pang et al., 2009) . Thus, it is unclear whether cognitive deficits observed in whole-body GIT1 knockout mice are due to abnormal brain function versus general functional impairment due to pulmonary insufficiency.
Here we use conditional neural-specific GIT1 knockout (NKO) mice to investigate cognitive deficits due to loss of function of GIT1 in the nervous system. Unlike whole-body GIT1 knockout, conditional neural-specific GIT1 knockout does not cause post-natal lethality. We find that these mice have deficits in both fear conditioning learning and working memory. We then utilize a proteomic approach to analyze hippocampi from GIT1-NKO mice to identify protein phosphorylation events that depend on the presence of GIT1. We discuss the relevance of our findings for GIT1 regulation of protein networks involved in synaptic functions, and dysregulation of these networks and functions in neuropsychiatric diseases.
Materials and Methods

GIT1 Conditional Neural Knockout Mice
Floxed Git1 mice (Schmalzigaug et al., 2009 ; Jackson Laboratories Mouse Genome Informatics symbol Git1 tm1.1Rtp ) and Nestin-Cre (B6.Cg-Tg (Nes-cre)1Kln/J) mice were generously provided by Dr. Guoping Feng (MIT). Floxed Git1 mice used here had been extensively (> 10 generations) backcrossed with C57BL/6 mice. Nestin-Cre mice were initially purchased from Jackson Laboratories (stock number 003771; genetic strain is the F2 hybrid of the closely related substrains C57BL/6 and C57BL/10) and then backcrossed with C57BL/6 mice. For breeding conditional GIT1 neural-specific knockout mice according to the established protocol required to prevent germline transmission of the Nestin-Cre transgene (Bates et al.,1999) , male Git1 flox/+ , Cre + transgenic mice were mated with female Git1 flox/flox Cre -mice to generate both neural knockout (GIT1-NKO; Git1 flox/flox Cre + ) and control (Git1 flox/flox Cre -) males for behavioral testing. For some experiments (see below), Nestin Cre mice were purchased from Jackson Laboratories for use as additional controls in behavior experiments. Genotyping was carried out under standard conditions utilizing a previously published protocol (Schmalzigaug et al., 2009 ).
Behavioral studies
Mice were group housed (4/cage) in a temperature and humidity controlled room and maintained on a reverse 12:12 light/dark cycle (7:00 am-7:00 pm) with ad libitum access to food and water. All behavior assays used male mice aged 8-12 weeks, and were performed during the light period under low level white light illumination. Experimental procedures were approved by the MIT institutional animal care and use committee under protocol 1012-102-15.
All behavioral studies were carried out with experimenter blinded to genotype. The last cage bedding change occurred ~24 hours prior to the beginning of behavior testing. For all assays, mice were habituated in the test facility in their home cages for 1 hour prior to starting the task. Cohort 1 was tested in the following behavioral tests: T-maze, 3-chamber social interaction, elevated plus maze, pre-pulse inhibition, and fear conditioning with at least four days between each behavioral experiment. Follow up cohorts were run in T-maze and fear conditioning only as these demonstrated differences between control and GIT1-NKO mice in the initial cohort.
T maze spontaneous alternation
Mice were placed in the start arm of the T-maze (5 cm wide x 28 cm long x 10 cm high; Stoelting) and allowed to freely explore the maze for 5 minutes. Arm entries were recorded and a correct alternation was defined as 3 consecutive arm entries into an arm not entered on the previous 2 trials. Chance performance in this task is 22%.
Three-chamber social interaction
Male mice were used across all cohorts. Both stranger 1 and stranger 2 were wild type male S129 Sv males (Jackson laboratory) with matched age and body weight to test mice. Stranger mice were habituated by placing them inside an inverted wire cup for 30 minutes, two sessions per day for three consecutive days before experiments. Each stranger mouse was used maximally two times per day. The social test apparatus was made of a clear plexiglass box (65 (L) × 44 (W) × 30 (H) cm) with removable floor and partitions dividing the box into left, center, and right chambers. Center chamber (21 cm x 22 cm) is half the width of the left (21 cm x 44 cm) and right chamber (21 cm x 44 cm). These three chambers were interconnected with 5 cm openings between each chamber which can be closed or opened manually with a lever operated door. The inverted wire cups to contain the stranger mice were cylindrical, 10 cm in height, a bottom diameter of 10 cm with the metal bars spaced 0.8 cm apart. A weighted cup was placed on top of the inverted wire cups to prevent the test mice from climbing onto the wire cup. Each wire cup was used only one time per day then followed by extensive clean with 75% ethanol and water at the end of the test day. During the habituation phase, an empty wire cup was placed into left and right chamber, and the test mouse was placed into the middle chamber and allowed to explore for 15 minutes, with the doors into both side chambers open. During the sociability test phase, the test mouse was firstly gently introduced to the middle chamber with the doors to both side chambers closed, and an unfamiliar mouse (S1) was placed under the inverted wire cup in one of the side-chambers and a toy object (O) was placed under the inverted wire cup placed on the opposite side chamber. The location of the stranger mouse and object was counterbalanced between test trials to exclude side preference. The experimenter then lifted up the doorways to both side chambers simultaneously, and the test mouse was allowed to explore all three chambers for 15 minutes. During the social novelty test phase, the test mouse was again gently introduced into the middle chamber with the doors to both side chambers closed. Then a novel mouse (S2) was placed under the inverted wire cup, replacing the toy object (O) in one of the side-chambers. The experimenter then lifted up the doorways to both side chambers simultaneously, and the test mouse was allowed to explore all three chambers for an additional 15 minutes. Time spent in close proximity to the stranger mice or toy object was analyzed using Noldus Ethovison software.
Elevated plus maze
Mice were placed in a closed arm of an elevated plus maze (Arm width = 10 cm, arm length = 50 cm, wall height = 30 cm, distance from floor = 55 cm; Coulbourn Instruments) and allowed to freely explore the maze for 5 minutes. Total time in the open and closed arms and the total distance travelled was recorded automatically via video tracking software (EthoVision).
Acoustic startle response and prepulse inhibition
Each test chamber was equipped with a loudspeaker mounted 25 cm above the holding cylinder and a commercial startle reflex system (SR Lab, San Diego Instruments, CA). Individual mouse was placed inside the plexiglass holding cylinder mounted on a plexiglass platform. A piezoelectric accelerometer located beneath the platform was used to transform startle responses into units based on force and latency of startle. Data were collected at 250 samples/s and the maximum voltage attained on each trial was used as the dependent variable. Each test session started with a 5 minute acclimation period in the presence of 65 dB acoustic background noise followed by five 120 dB startle pulses. Pre-pulse trials followed the initial 120 dB startle acclimation. Each pre-pulse stimulation was 20 ms in duration, followed by a 40 ms startle stimulus of 120 dB. PPI was recorded for pre-pulse intensities of 70, 75, 80, 85 and 90 dB, and no stimulus. Each prepulse trial was administered ten times in a random order. Trials of 120 dB alone were randomly interspersed within the pre-pulse trials and used for comparison with the prepulse trials. The percent PPI was calculated using the formula [100−(response to pre-pulse + 120 dB)/(response for 120 dB alone)×100]. Acoustic startle trials were followed the PPI trials. Startle trials consisted of 40 ms pulses at 0 (no stimulus), 70, 75, 80, 85, 90, 95, 100, 105, 110, 115 , and 120 dB. Each trial was presented five times in a randomized order.
Fear Conditioning
Training: Mice were placed in one of two fear conditioning chambers (Coulbourn Instruments) and allowed to freely explore for 2 minutes (baseline). After 2 minutes, mice were presented with a 30s white noise (85dB) conditioned stimulus (CS) with a co-terminating 2s foot shock (0.75mA; US). Freezing was measured continuously for 2 minutes after the first CS-US presentation (immediate) which also served as the inter-trial interval (ITI). Mice were then presented with a second 30s CS co-terminating 2s US pairing, followed by 30 seconds before being removed from the training chamber. All freezing behavior was automatically scored by Freeze Frame software (Coulbourn) defined as a complete absence of movement other than respiration for a full second.
Context Test: 24 hours after initial training, mice were placed back into the original training chamber and freezing was measured continuously for 5 minutes (context).
Cued Test: One hour after contextual testing, the chambers were altered (grid floor covered with a smooth plastic floor (tactile); wall cues added (visual); vanilla extract scent added (olfactory)) and freezing was measured for 2 ½ minutes (Pre-CS). Then, the 85dB white noise was presented and freezing was measured continuously for 2 ½ minutes (cued).
Behavioral Data Analysis
All behavioral data were collected by automated methods to remove potential confounds associated with human scoring, with the exception of spontaneous alternation in the T-maze, which was scored by the experimenter in real time, blinded to genotype. T-tests or repeated measures analysis of variance (ANOVA) were utilized where appropriate. All data were analyzed via SPSS v. 24
Total and Phospho-proteomics
Total hippocampal proteins and phospho-proteins were detected by quantitative LC-MS/MS methods. Mass spectrometry detection and quantitation was performed in quadruplicate with paired samples consisting of male, 8-12 week old matched pairs (either littermates or agematched) of control and GIT1-NKO mice. Following decapitation, mice heads were dipped in liquid nitrogen for 5 seconds to rapidly cool, but not freeze, the brain. Hippocampi were dissected rapidly on a cooling tray, and placed in Covaris bags (tissueTUBE TT05, Covaris), which were then flash frozen in liquid nitrogen. The frozen tissue was pulverized according to the manufacturer's protocol on a Covaris CP02 Cryoprep Pulverizer. The pulverized tissue was lysed in 8M urea with protease and phosphatase inhibitors. The protein lysate (typical total yield ~1-1.5 mg per hippocampus) was reduced, alkylated, and double digested with both Lys-C and Trypsin overnight. Equivalent amounts of tryptic peptides (~1 mg) from each sample were labeled with TMT-10 reagent (Thermo Fisher Scientific) and the individual label incorporation was checked via LC-MS/MS. All samples had greater than 95% label incorporation. The labeled digests were combined and fractionated using basic reverse phase (bRP) chromatography (with an Agilent HPLC system) into 2 fractions for proteome analysis and 12 fractions for phosphopeptide analysis. Fractionation decreases sample complexity and increases the dynamic range of detection. From each fraction, 5% of the total volume was used for proteomic analysis while the remaining 95% was used for phosphopeptide enrichment using established protocol for Immobilized Metal Affinity Chromatography (IMAC) developed at the Broad Institute (Mertins et al., 2016; Mundt et al., 2018) . The proteome and the phosphoproteome data were acquired on a Q-Exactive+ mass spectrometer (Thermo Fisher Scientific). Peptide spectrum matching and protein identification was performed using Spectrum Mill (Agilent). Peptide identification false discovery rates (FDRs) were calculated at 3 different levels: spectrum, distinct peptide, and distinct protein. Peptide FDRs were calculated in SM using essentially the same pseudo-reversal strategy evaluated by Elias and Gygi (Elias and Gygi 2010) and shown to perform the same as library concatenation. A false distinct protein ID occurs when all the distinct peptides that group together to constitute a distinct protein have a deltaForwardReverseScore ≤ 0. We adjusted settings to provide peptide FDR of 1-2% and protein FDR of 0-1%. SM also carries out sophisticated protein grouping using the methods previously described (Neshvizhskii and Aebersold 2005). Only proteins with >2 peptides and at least 2 TMT ratios in each replicate are counted as being identified and quantified. For each matched pair of control and GIT1-NKO hippocampi, Spectrum Mill calculated a fold-change for each protein or phospho-site (psite). Our initial criterion for a GIT1-regulated 'hit' was a requirement that fold-changes from all four matched sample pairs had to be coherent, i.e. in the same direction (up or down). We then normalized the mean of these four psite fold changes to the mean of the fold changes of the corresponding proteins induced by GIT1 neural knockout. For quantitating protein levels and fold changes, only peptides unique to individual proteins were counted; thus, peptides that are identical across multiple gene homologs were not counted. We then ranked our normalized psite fold change list by the magnitude of the change induced by GIT1 neural knockout. Lastly, we imposed a minimum fold change threshold of 25% (up or down); the 639 phospho-protein changes meeting these criteria are shown in Supplemental Table 7 .
GO category enrichment analyses
GO category enrichment analysis for all detected hippocampal proteins ( Figure 2B ) and GIT1-regulated phospho-proteins ( Figure 3B ) was performed using the Enrichment Analysis (PANTHER) web tool at www.geneontology.org, which output both fold-enrichment values and corrected false discovery rate p values (Supplemental Table 2 ). To generate the treemaps in Figures 2B and 3B, we started with the indicated sets of enriched cellular component GO categories with corrected p values < 1e -05 . We removed GO categories that could not be linked to a specific cellular component (e.g. "Cell" and "Intracellular"), and then we manually annotated each remaining GO category to its corresponding specific cellular component (e.g. the GO category "Chromatin" was annotated as being in the "Nucleus" component). Our manually annotated cellular components were the branches (shown as distinct colors on the treemap; branch names are shown as white text in each branch) of the treemap, with enriched GO categories as the leaves (individual lettered boxes in each branch). Leaf size was determined by the fold-enrichment value for each GO category. GO cellular component category enrichment among GIT1-regulated phospho-peptides (Supplemental Figure 3 ; Supplemental Table 7) was also quantitated and visualized with the BiNGO plugin (Maere et al., 2005) 
Molecular interaction and function enrichment database search
Molecular interaction and function (i.e. biological pathway) enrichment was performed using the expert curated biological pathway web tool Reactome (www.reactome.org). Using the 'Analyze Data' function, mouse protein sets (see Results) were entered, converted to human equivalents, and evaluated for pathway over-representation using default settings.
Results
Cognitive deficits in neural-specific conditional GIT1 knockout mice
To analyze the behavioral consequences of GIT1 dysfunction in the context of intact neural circuits in vivo, we utilized a GIT1 knockout mouse. Three distinct alleles generating whole-body GIT1 knockout mice have been created, and mice with these knockout alleles have several learning and memory deficits (Schmalzigaug et al, 2009; Menon et al., 2010; Won et al., 2011) . However, whole-body GIT1 knockout mice also have greatly reduced postnatal survival (Schmalzigaug et al., 2009; Won et al., 2011) and impaired cardiac, pulmonary, and skeletal dysfunction (Pang et al., 2009; Menon et al., 2010; Pang et al., 2011) potentially confounding the interpretation of behavioral data in these mice. To overcome these previous limitations and create a model system to investigate the neural-specific functions of GIT1, we utilized the Cre/lox system by crossing Nestin-Cre expressing driver mice with one of the previously generated mouse strains carrying floxed GIT1 alleles (Schmalzigaug et al., 2009 ) to conditionally inactivate GIT1 in the central and peripheral nervous systems (GIT1-NKO mice; Figure 1A ; Supplemental Figure 1) . Analysis of adult hippocampal tissue from these neuralspecific GIT1-NKO mice showed almost undetectable expression of GIT1 (Supplemental Figure 1) . These mice had normal post-natal survival rates in contrast to the previously reported whole-body GIT1 knockout mice, but were slightly smaller in overall body size similar to the whole-body GIT1 knockout mice (data not shown).
To broadly assess the behavioral consequences of neural-specific loss of GIT1, GIT1-NKO mice were put through a battery of tests. To assess cognition, GIT1-NKO mice were first tested in both contextual fear conditioning, which assesses a memory process dependent on both the hippocampus and the amygdala (Kim & Fanselow, 1992; Muller et al., 1997) , and cued fear conditioning, which assesses amygdala-dependent memory processes (Muller et al., 1997) . Figure 1B shows that GIT1-NKO mice exhibit both hippocampus-and amygdala-dependent fear conditioning deficits when compared to Nestin-Cre expressing, non-floxed GIT1 +/+ control mice. This did not simply reflect a difference in locomotor activity levels, as GIT1-NKO mice had no difference in freezing responses during the training period as compared to control mice (p = 0.1315; two-tailed t-test). Next, the mice were tested in a spontaneous alternation cortex-and hippocampus-dependent working memory T-maze task (Lalonde, 2002; Dudchenko, 2004) . Figure 1C shows that GIT1-NKO mice had virtually no ability to recall arm visits in the T-maze, suggesting a severe working memory deficit. In contrast, GIT1-NKO mice had no deficits in social interaction ( Figure 1E , three-chamber social interaction test, reviewed in Silverman et al., 2010) or prepulse inhibition ( Figure 1F ), a test of sensorimotor gating, which is defective in schizophrenia patients (e.g. Braff et al., 1978) . In addition, GIT1-NKO mice scored equivalent to control mice in the elevated plus maze test (Figure 1D ), indicating that these mice have normal levels of anxiety. These results demonstrate that GIT1 function is critical specifically for cognitive learning and memory processes, and are in accordance with deficits in contextual and cued fear conditioning reported previously for whole-body GIT1 knockout mice.
Proteome-wide identification of GIT1-regulated phosphorylation events in hippocampus
GIT1 regulation of synaptic processes might occur simply by scaffolding to facilitate the proximal localization of key synaptic machinery components required for function. However, given the ability of GIT1 to regulate multiple kinase signaling cascades (Zhou et al., 2016) , GIT1 may also modulate synaptic processes by controlling the phosphorylation states of key synaptic proteins. To address this question in an unbiased manner, we employed mass spectrometrybased proteomics to discover GIT1-regulated phosphorylation events in mouse hippocampus.
Notably, this analysis was proteome-wide-i.e. not restricted to synaptic proteins-as we used whole hippocampal lysate as the input into the proteomic pipeline. To preserve protein phosphorylation states in the hippocampi, mouse heads were quickly chilled after decapitation by a brief dip in liquid nitrogen (Jordi et al., 2013) . Following dissection on a surface kept at -20 degrees, hippocampi were flash frozen in liquid nitrogen and then put through a standardized lysis process optimized for phospho-proteomics (Mertins et al., 2016; Mundt et al., 2018; and see methods) . Hippocampal lysates from wild-type and GIT1-NKO mice (four biological replicates of each) were then subjected to immobilized metal affinity chromatography enrichment-based phospho-peptide mass spectrometry detection and quantitation, as well as parallel proteomic detection and quantitation of total protein levels (Figure 2A ).
To our knowledge, these proteomic data represent the most comprehensive survey to date of proteins and phospho-proteins expressed in the hippocampus (Figure 2A) . We found that 8704 genes expressed at least one characterized protein product; these genes comprise nearly 40% of the protein coding genes in the mouse genome according to Gencode (http://www.gencodegenes.org/mouse_stats.html) (Supplemental Table 1 ). Confirming an expected expression pattern, these proteins include receptors for the major neurotransmitter systems that have been described in the hippocampus: glutamate, GABA, acetylcholine, dopamine, serotonin, and norepinephrine (Supplemental Table 1 ; Vizi & Kiss, 1998; González-Burgos & Feria-Velasco, 2008) . Gene ontology (GO) cellular component category enrichment analysis (using PANTHER; Figure 2B and Supplemental Table 2) showed the expected over-representation of proteins involved in synapses and neurites, and also highlighted the important roles of the nucleus, mitochondria, and the cytoskeleton, as well as other cellular components, in cells of the hippocampus. Similar GO category enrichment analyses for biological process and molecular functions are shown in Supplemental Table 2 . Interestingly, our data support the notion of a role for the hippocampus in schizophrenia pathology (Harrison, 2004) ; of the 58 single-gene GWAS loci containing variants associated with schizophrenia risk identified by Ripke et al (2014) , 36 of these express proteins we detect in the hippocampus (Supplemental Table 6 ). Lastly, as a key control, our proteomic data showed the expected large decrease in GIT1 levels in the neural knockout mice' hippocampi ( Figure 2C ; remaining residual levels of GIT1 are likely from vasculature). In addition, the GIT1-associated PIX proteins (ARHGEF6 and ARHGEF7) are downregulated by GIT1-NKO; this lack of stability of PIX proteins in the absence of GITs has been observed previously (Won et al., 2011; Zhou et al., 2016) . These data underscore the variety and complexity of protein expression and function in the hippocampus.
While it is well-appreciated that regulation of protein phosphorylation is a key aspect of synaptic plasticity (Woolfrey & Dell'Acqua, 2015) , our data also indicate the staggering complexity of protein phosphorylation in the hippocampus, with 29,625 unique phosphopeptides detected on 6596 proteins, many of which had multiple phosphorylation sites/states (Supplemental Table 3 ). By cross-referencing these phospho-peptides with published lists of synaptic proteins (Boyken et al., 2013; Collins et al., 2006) , we can deduce that, at synapses, there may be up to 800 and 7526 distinct phospho-peptides (many synaptic proteins contain multiple phospho-peptides) on the pre-and post-synaptic sides, respectively ( Figure 2D ).
Searching for these phosphorylation states in the PhosphoSite public protein post-translational modification database (www.phosphosite.org) revealed both known and previously unreported phosphorylation events, reflective of the depth of the proteomic analysis performed. For example, 14 phosphorylation sites were detected in GIT1, and all of those are present in the PhosphoSite database (Supplemental Table 4 ). In contrast, 35 phosphorylation sites were detected in the schizophrenia risk gene product GRIN2A, and 7 of those were apparently novel (i.e. not present in the PhosphoSite database; Supplemental Table 4 ). Global analysis of Gene Ontology (GO) cellular component category enrichment in the total set of all phospho-proteins in our data (Supplemental Table 3 ) using the BiNGO app in Cytoscape (http://www.cytoscape.org/) revealed 275 enriched (p < 0.01) GO categories, comprising many basic and neuron-specific cellular components (Supplemental Table 5 ; hierarchical network visualization in Supplemental File 1).
Parallel proteomic detection and quantitation of total protein levels allowed for normalization of phospho-peptide levels to the corresponding levels of total protein in wild-type and GIT1-NKO samples; these normalized phospho-peptide levels were then used to quantitate phosphorylation state changes induced by GIT1 knockout. Our initial criteria for a 'hit' in this assay were: 1) a GIT1 knockout-induced change in phosphorylation state in the same direction (up or down) across all four of our paired replicate samples; and 2) a minimum change up or down of 25%. A total of 639 protein phosphorylation state changes, of at least 25% up or down, were observed consistently across all samples (Supplemental Table 7 ; see Methods section for details of quantitation method).
Some of the proteins with phosphorylation states altered by GIT1 knockout are known to directly interact or associate with GIT1, including ARHGEF6 (Zhou et al., 2016) , GIT2 , PCLO , CNKSR2 (Lim et al., 2014) , CAMK2A and CAMK2B (Pang et al., 2008) , PTK2 (Zhao et al., 2000) , MYO18A (Hsu et al., 2010) , PPFIA2 , RIMS1 , NCK1 (Frese et al., 2006) , and ERC2 (Ko et al., 2003b) ; or to associate with ARHGEF6/7, including PAK1 and PAK2 (Bagrodia et al., 1999) , SHANK1 (Park et al., 2003) , and NSF (Martin et al., 2006) . Indeed, we have replicated several of these reported interactions with GIT1 (Supplemental Figure 2) . The GIT1 interactor NCK1 also interacts with the kinase TNIK (Fu et al., 1999) , and TNIK phosphorylates serine 315 in CAMK2B ; serine 315 phosphorylation was upregulated by GIT1 knockout, suggesting that the GIT1-NCK1 interaction may inhibit TNIK. Supporting this notion, phosphorylation of a δ-catenin serine targeted by TNIK (serine 528 in CTNND2; ) was also slightly upregulated by GIT1 knockout (by ~16%, which was less than the 25% threshold we set for 'hits'; data not shown). Taken together, these data indicate that phosphorylation states of proteins may be regulated via their interactions with the GIT1-ARHGEF6/7 complex and kinases that are regulated by this complex.
Because GIT1 stimulates the activity of p21-activated kinases (PAKs) and microtubuleassociated kinase (MAPK) (Kim et al., 2017) , and GIT1 has been reported to scaffold MEK-ERK MAP kinases (Yin et al, 2004; Yin et al, 2005; Zhang et al, 2009 ), we anticipated that GIT1 knockout would decrease the phosphorylation of known PAK and/or MAPK targets. Indeed, the phospho-site that was the most downregulated by GIT1 knockout, serine 92 on SEPT3, may be a PAK target, as PAKs phosphorylate septins in yeast (Versele & Thorner, 2004) . In addition, another one of the strongest effects of GIT1 knockout was a decrease in phosphorylation of the microtubule destabilizer STMN1 at serine 63; this serine is known to be a target of PAK (Wittmann et al., 2004) . Likewise, GIT1 knockout also decreases the phosphorylation of ARHGEF2, ARHGDIA, and SPEN, which are known targets of PAK (Aslan et al., 2013; Shin et al., 2009 , Vadlamudi et al., 2005 . Phosphorylation of PAK1 serine 144 and PAK2 serine 141, which get autophosphorylated upon PAK1/2 binding to GIT1/PIX (e.g. Kim et al., 2017) , were downregulated by GIT1 knockout. MYO18A phosphorylation was also decreased by GIT1 knockout; MYO18A is a known PAK interactor (Hsu et al., 2010) . Lastly, several other sites of phosphorylation decreased by GIT1 knockout (such as NSF serine 207, NSMF serine 72, DIRAS2 serine 35, and SCN1A serine 607) match, or nearly match, key characteristics of optimal PAK phospho-acceptor sites (R at position -2 and large hydrophobic residues-W, I, V, Y-at +1 to +2 relative to the phosphorylated serine; Rennefahrt et al., 2007 ; these phosphosites are highlighted in Supplemental Table 7 ). In addition, the phosphorylation of numerous KSP motifs in neurofilament H was decreased by GIT1 knockout; these motifs can be phosphorylated by MAPK (Veeranna et al., 1998) . Thus, known GIT1 interactions and/or PAK/MAPK targets account for a subset of the GIT1-regulated phosphorylation state changes observed here; for the remainder, mechanisms of regulation are unknown, and these may represent previously undiscovered targets of PAKs, MAPKs, or other kinases.
Biological network enrichment analysis of GIT1-regulated phospho-proteins
We detected 73 proteins with phosphorylation states that were robustly regulated (more than 2-fold) by GIT1 knockout: 45 were downregulated, and 28 were upregulated ( Figure 3A) .
We tested whether synaptic proteins were enriched in this set of GIT1-regulated phosphoproteins. We used the union of lists of biochemically purified pre-synaptic proteins (Boyken et al., 2013) and post-synaptic proteins (Collins et al., 2006) as a reference list of 'synaptic proteins', which totaled 1572 proteins, or ~7%, out of a total of 22032 protein-encoding genes in the mouse genome according to Gencode (http://www.gencodegenes.org/mouse_stats.html). The occurrence of synaptic phosphoproteins in our GIT1-regulated set by pure random chance would therefore be 5 (i.e. 7% of 73).
In fact, we observed 27 synaptic proteins among the set of phospho-proteins regulated at least 2-fold by GIT1. This enrichment of synaptic phospho-proteins regulated by GIT1 was statistically significant ( Figure 3A ; p < 0.0001 by Chi-square test with Yates correction). Accordingly, GO cellular component enrichment analysis (using PANTHER) among GIT1-regulated hippocampal phospho-proteins ( Figure 3B) showed that the vast majority of the enriched categories, as ranked by the degree of fold enrichment, involved V-type ATPases and synaptic components (see Supplemental Table 9 for a list of all enriched cellular component categories; the cell compartment specific subset of these categories visualized the in treemap in Figure 3B is listed in Supplemental Table 10 ). Indeed, the V-type ATPase categories may also be considered as synaptic components, as V-type ATPases function to facilitate loading of synaptic vesicles with neurotransmitters (Edwards, 2007) . These data indicate that one of GIT1's primary roles in the hippocampus is to regulate levels of synaptic protein phosphorylation.
Inspection of the set of synaptic proteins with phosphorylation states regulated by GIT1 indicated that these proteins fell into the same functional categories as has been reported for GIT1-associated proteins in the brain (Zhou et al., 2016) . Of synaptic phosphoproteins changed by more than 2-fold, 9 are involved in presynaptic vesicle functions, 10 are involved in postsynaptic density functions, and 16 regulate the cytoskeleton. For example, phospho-SEPT3 (serine 92) was downregulated by more than 70% by GIT1 knockout. SEPT3 is known to be a phosphoprotein localized to presynaptic nerve terminals, and it appears to be involved in synaptic vesicle recycling (Xue et al., 2004) . Phosphorylation of serine 499 of the post-synaptic density scaffolding protein SHANK1 was upregulated more than 3.1-fold. DOCK10 phosphorylation at tyrosine 1980 was downregulated by nearly 58%. DOCK10 is a dendritic spine cytoskeleton regulator that acts through effects on CDC42, N-WASP, PAK3, and RAC1 (Jaudon et al., 2015) . Phosphorylation of another neuronal cytoskeleton regulator, MACF1 (serine 7245), was downregulated by 56%. Both DOCK10 and MACF1 have been reported to regulate dendrite (or dendritic spine) and axon growth (Jaudon et al., 2015; Ka & Kim, 2016) .
Thus, GIT1 regulates the phosphorylation states of synaptic proteins associated with the functions of synaptic vesicles, the post-synaptic density, the neuronal cytoskeleton, and axon and dendrite growth.
To identify the protein networks with phosphorylation states dependent on the presence of GIT1 in an unbiased manner, we performed pathway enrichment analysis with the Reactome curated pathway database (www.reactome.org). This tool uses a set of user input seed proteins, in the present case identified in our unbiased proteomics experiment, to search a manually curated database covering protein-protein interactions across a wide swath of human molecular physiology and disease, and then generates error-corrected false discovery rate (FDR) values for pathway over-representation. Included in this database are brain pathways that are specific to neurons in general, specific types of neurons (defined by neurotransmitter type), and glia.
Initially, we tested a seed set consisting of all phospho-proteins identified in control or GIT1-NKO hippocampi (6596 phospho-proteins, many of which were phosphorylated at multiple sites; see Supplemental Table 3 ). No pathways were enriched in this 'total hippocampal phosphoproteome' seed set; all pathways had a FDR value > ~0.9. We next used a seed set consisting of all phospho-proteins regulated by more than 30% (up or down; 512 phospho-proteins; see Supplemental Table 7 ) by GIT1 neural knockout. With this 'GIT1-regulated hippocampal phospho-proteome' seed set, four pathways had FDR values < 0.05 (Supplemental Table 8 ).
The most statistically enriched pathway was 'Neuronal system', consistent with the notion that GIT1 regulates phospho-proteins in neurons, and indicating that the Reactome database is sufficiently annotated to detect organ-specific pathways. The other statistically significantly enriched pathways involved molecular interactions that connect and support synapses (e.g.
neurexin-neuroligin interactions)
. A number of nominally significant pathways (FDR < 0.1) involved mechanisms of neurotransmission at synapses common to several neurotransmitter types, in particular including excitatory glutamatergic synapses. A growing body of genetic research implicates both neurexin-neuroligin interactions and excitatory glutamatergic synapses with cognition and neuropsychiatric disease (Doherty et al., 2012; Hall et al., 2015) . Thus, these unbiased Reactome-generated observations of statistically enriched pathways involving phospho-proteins regulated by GIT1 suggest that defects in GIT1 signal transduction functions at excitatory synapses may underlie pathology in neuropsychiatric diseases.
Schizophrenia risk genes in GIT1-regulated synaptic phospho-protein networks
Having identified GIT1-regulated phospho-proteins at the synapse, we next asked whether any of these proteins have been associated with risk for schizophrenia. To address this question, we intersected the list of GIT1-regulated synaptic phospho-proteins (Supplemental Table 7 ) with schizophrenia risk genes identified in a study of common variation in schizophrenia patients (Ripke et al., 2014) . This analysis revealed three GIT1-regulated synaptic phospho-proteins that have common variants that are associated with risk for schizophrenia: RIMS1, GRIN2A, and CNKSR2. Notably, GIT1 has been reported to directly interact with one of these proteins: CNKSR2 (Lim et al., 2014) ; we have been able to reproduce observation of this interaction using a co-immunoprecipitation assay in HEK293 cells (Supplemental Figure 2) . The effect of GIT1 knockout on the phosphorylation status of these three proteins is shown in Figure 4A (black bars). Notably, two of these GIT1-regulated, schizophrenia-associated proteins (CNKSR2 and GRIN2A) are also associated with intellectual disability (Endele et al., 2010; Houge et al., 2012) . We next constructed pre-and post-synaptic GIT1-schizophrenia risk gene interaction networks (Figure 4B and C) using GIT1 and RIMS1 (presynaptic), or GIT1 and CNKSR2 (postsynaptic) as starting nodes, and then adding interacting nodes from the sets of GIT1-regulated phospho-proteins (Supplemental Table 7) known to be expressed in those two synaptic compartments, particularly in excitatory glutamatergic synapses (Boyken et al., 2013; Collins et al., 2006) , with interactions (edges) from the BioGRID protein interaction database (https://thebiogrid.org/). The effect of GIT1 knockout on phosphorylation of a subset of these pre-and post-synaptic proteins is shown in Figure 4A (grey bars). Several proteins in these networks are known to be encoded by autism (Sanders et al., 2015) or developmental delay (McRae et al., 2017) risk genes (marked in Figure 4B ) and it is possible that several more of the genes encoding these networks' proteins will be identified as schizophrenia risk genes in future studies as schizophrenia GWAS and sequencing sample sizes increase. Future work will be required to determine how these phosphorylation changes affect the functioning of GIT1-regulated pre-and post-synaptic networks, and the behavioral consequences of the effects on these networks; however, the current literature contains some clues. For example, GIT1 knockout dramatically induces phosphorylation of CAMK2B at threonine 325, which is a residue in its actin-binding domain; this may allow CAMK2B to dissociate from actin during signaling events that induce synaptic plasticity and dendritic spine actin remodeling (Kim et al., 2015) , suggesting that GIT1 may function to negatively regulate synaptic plasticity-associated dendritic remodeling through suppression of CAMK2B phosphorylation. In addition, mutation of several phosphorylated residues in GRIN2A to alanine, including GIT1-regulated S1291 and Y1292, caused deficits in Y-maze working memory (Balu et al., 2016) similar to the effect of GIT1 neural knockout observed here ( Figure 1C) . The identification of pre-and post-synaptic networks containing GIT1-regulated phospho-proteins, including schizophrenia and intellectual disability risk genes, clearly suggests the central role of GIT1-regulated proteins in a hot spot for neuropsychiatric disease pathology-the excitatory glutamatergic synapse.
Discussion
Building on recent efforts to elucidate the genetic architecture of neuropsychiatric diseases, the delineation of components, interactions, and signal transduction flow in key molecular networks and pathways that are disrupted in these diseases is a critical next step for the field. Here we study one such component with function and expression altering genetic variation in schizophrenia and neurodevelopmental disorders: the synaptic scaffolding and signaling protein GIT1. We utilize behavioral testing and phospho-proteomic analysis in mice with conditional neural-specific knockout of GIT1 to identify aspects of cognition, as well as hippocampal phosphorylation signaling events that are regulated by GIT1. We find that GIT1 neural knockout mice have cognitive deficits in associative learning and working memory, while social interaction, sensorimotor gating, and anxiety behaviors were normal. Our proteomic analyses indicate that GIT1 regulates phosphorylation states within networks of pre-and post-synaptic proteins. Excitingly, this includes a set of proteins within these synaptic networks that have been implicated as risk factors in genetic studies of schizophrenia and neurodevelopmental disorders. These data suggest that deficits in GIT1 functioning in synaptic networks may contribute to cognitive dysfunction in neuropsychiatric diseases.
Copy number variation at the GIT1 locus, including both deletions and duplications, has been reported in patients with neurodevelopmental disorders (Uddin et al., 2016) ; these patients generally have developmental delay and intellectual disability. Here we identified cognitive deficits in a mouse model with complete nervous system-specific knockout of GIT1. Previous studies reporting associative learning deficits in GIT1 knockout mice (Schmalzigaug et al., 2009; Won et al., 2011; Menon et al., 2010; Martyn et al., 2018) utilized whole-body knockout, which produces post-natal cardiovascular dysfunction and lethality (Pang et al., 2009; Schmalzigaug et al., 2009) . In contrast, mice studied here with neural-specific GIT1 knockout had normal postnatal survival. Consistent with whole-body knockout mice, neural-specific GIT1 knockouts had an associative learning deficit in the fear conditioning test (Figure 1 ). In addition, we found that neural-specific GIT1 knockout mice had a severe working memory deficit in the spontaneous alternation test (Figure 1) . These findings suggest functional deficits in both the hippocampus and cortex, which are key brain regions involved in associative learning and working memory (Kim & Fanselow, 1992; Lalonde, 2002) .
To begin to elucidate the molecular mechanism of GIT1's role in learning and memory, we performed phospho-proteomic analysis of GIT1-regulated signaling in the hippocampus. The set of hippocampal phospho-proteins regulated by GIT1 contained many synaptic proteins that fell within several functional categories: presynaptic vesicle trafficking, post-synaptic receptor clustering, and post-synaptic dendritic spine cytoskeleton regulation. Excitingly, several GIT1-regulated hippocampal phospho-proteins in these functional categories have common genetic variants associated with schizophrenia: RIMS1, GRIN2A, and CNKSR2. (The complete list of GIT1-regulated phospho-proteins that are schizophrenia GWAS genes is shown in Supplemental Table 11 .) These data link GIT1 to an apparent hotspot for schizophrenia pathology-the excitatory glutamatergic synapse.
GIT1 regulation of phosphorylation of the presynaptic vesicle trafficking protein PCLO is especially intriguing in light of the recently reported role of GIT1 in negatively regulating presynaptic vesicle release probability, possibly by regulating actin dynamics at the active zone (Montesinos et al., 2015) . PCLO also appears to negatively regulate synaptic vesicle exocytosis via effects on actin (Waites et al., 2011) . We hypothesize that GIT1-regulated phosphorylation of PCLO may facilitate PCLO's actions on the active zone actin cytoskeleton. This effect may be modulated by neuronal activity, as depolarization also regulates a subset of the GIT1-regulated phospho-sites in PCLO (Kohansal-Nodehi et al., 2016) . These will be important questions to address in future studies.
GIT1 regulation of phosphorylation of the schizophrenia-associated NMDA receptor subunit GRIN2A may play a role in the working memory deficit we observed in the spontaneous alternation test. Two GRIN2A phosphorylation sites that had decreased levels of phosphorylation in GIT1-NKO mice (serine 1291 and tyrosine 1292) may be required for performance of this task- Balu and colleagues (2016) found that mice with these two residues mutated to alanine and phenylalanine, respectively, showed a deficit in the spontaneous alternation test.
In schizophrenia patients, several rare coding/splicing variants of GIT1 have been identified Purcell et al., 2014; Genovese et al., 2016) . Some of these variants impair GIT1 signaling via activation of PAK3 kinase (Kim et al., 2016) . To date, common variation at the GIT1 locus has not been associated with risk for schizophrenia (Ripke et al., 2014) ; however, as shown here, GIT1-regulated molecular networks include a number of genes at loci at which common variation has been associated with schizophrenia risk. To assess the effects of rare coding variants on GIT1-associated molecular networks, it will be necessary to study model systems expressing these variants, such as transgenic mice, or human induced pluripotent stem cell-derived neurons from patients with these coding variants.
These studies are currently under way in our laboratory. showing loss of GIT1 expression from brain regions. GIT2 (both long and short isoforms) was observed to be upregulated potentially as compensation for the loss of GIT1 protein.
However, this apparent compensatory upregulation of GIT2 was unable to replace GIT1's role in cognitive behaviors (Figure 1) , supporting the contention that GIT1 and GIT2 have different roles in the brain. (> 2-fold) phospho-proteins identified a small network of components including several known to be associated with GIT1 (for a review see Zhou et al., 2016) : cytoskeleton (proteins MACF1, ARHGAP21, CHRM4, STMN1, MAP1A, AKAP5, NEFH, SRCIN1, UBXN6, EIF3A, and SEPT3); neuron projection (proteins NSF, PAK1, SCN2A1, CHRM4, AKAP5, NEFH, and SRCIN1); and synapse (proteins RIMS1, CHRM4, GABRA4, AKAP5, SRCIN1, SYT7, SEPT3, and SHANK1); and one component not previously associated with GIT1 function: V-type ATPases (proteins ATP6V1H and ATP6V1C1). The enrichment of this last cellular component, V-type ATPases (which are critical components of synaptic vesicles; for a review see Morel & Poea-Guyon, 2015 ) is perhaps not surprising given GIT1's known regulation of synaptic vesicles (for a review see Zhou et al., 2016) .
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